Literature DB >> 11849769

The subthalamic nucleus has neurofibrillary tangles in argyrophilic grain disease and advanced Alzheimer's disease.

Petri Mattila1, Takashi Togo, Dennis W Dickson.   

Abstract

Neurofibrillary tangles (NFT) are present in the subthalamic nucleus (STN) of progressive supranuclear palsy and corticobasal degeneration, two sporadic tauopathies with preferential accumulation of tau with four repeats in the microtubule binding domain (4R tau). Since recent evidence suggests that argyrophilic grain disease (AGD) is also a 4R tauopathy, we hypothesized that the STN may also be affected in AGD. Tau immunostaining was used to evaluate NFT in the STN in 18 cases of AGD compared with 18 non-AGD cases matched for age, sex and Braak stage. AGD cases had significantly more NFT in the STN than non-AGD cases (P=0.008) with no relationship between NFT score and Braak stage. Surprisingly, NFT were also found in the STN of some non-AGD cases, notably in cases with advanced Braak stage (i.e. Alzheimer's disease). When AGD and non-AGD were considered as a whole there was a correlation between neurofibrillary degeneration in the STN and Braak stage. This study demonstrates that neurofibrillary degeneration is frequent in the STN in AGD, but also detected in non-AGD cases with advanced Braak stage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849769     DOI: 10.1016/s0304-3940(02)00006-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

Review 1.  Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies.

Authors:  Yoshinari Miyata; John Koren; Janine Kiray; Chad A Dickey; Jason E Gestwicki
Journal:  Future Med Chem       Date:  2011-09       Impact factor: 3.808

2.  A family with Parkinsonism, essential tremor, restless legs syndrome, and depression.

Authors:  A Puschmann; R F Pfeiffer; A J Stoessl; R Kuriakose; J L Lash; J A Searcy; A J Strongosky; C Vilariño-Güell; M J Farrer; O A Ross; D W Dickson; Z K Wszolek
Journal:  Neurology       Date:  2011-05-10       Impact factor: 9.910

3.  Spatial patterns of the tau pathology in progressive supranuclear palsy.

Authors:  Richard A Armstrong; Nigel J Cairns
Journal:  Neurol Sci       Date:  2012-03-13       Impact factor: 3.307

4.  The MAPT p.A152T variant is a risk factor associated with tauopathies with atypical clinical and neuropathological features.

Authors:  Eleanna Kara; Helen Ling; Alan M Pittman; Karen Shaw; Rohan de Silva; Roberto Simone; Janice L Holton; Jason D Warren; Jonathan D Rohrer; Georgia Xiromerisiou; Andrew Lees; John Hardy; Henry Houlden; Tamas Revesz
Journal:  Neurobiol Aging       Date:  2012-05-16       Impact factor: 4.673

5.  Primary Age-Related Tauopathy in Human Subcortical Nuclei.

Authors:  Keqing Zhu; Xin Wang; Bing Sun; Juanli Wu; Hui Lu; Xiaoling Zhang; Huazheng Liang; Dandan Zhang; Chong Liu
Journal:  Front Neurosci       Date:  2019-05-29       Impact factor: 4.677

Review 6.  Chaperone signalling complexes in Alzheimer's disease.

Authors:  John Koren; Umesh K Jinwal; Daniel C Lee; Jeffrey R Jones; Cody L Shults; Amelia G Johnson; Laura J Anderson; Chad A Dickey
Journal:  J Cell Mol Med       Date:  2009-04       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.